Daily Stock Opinions and Ratings

Opinions

Brian MaddenCineplex IncCGX.TODON'T BUYAug 30, 2017

The market darling for quite a long time. It did very well from about 2011 through to earlier this year. In the course of thriving and prospering, the stock got very richly priced. Trading at about 30X earnings. When you have a company trading at that multiple, and not really growing their earnings at a commensurate rate, it is very vulnerable to any short-term swing in sentiment. Hollywood has not come out with a good slate of movies this summer, which has really impacted them. He would be wary of the stock until things started to improve.

Brian Madden

Unlock Rating

$36.93

Stock price when the opinion was issued

$11.74

As of Jun 19, 2026. Market Open.

other services

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica Track your Stocks in your Watch List

You might be interested:

TRADE

He loves movies. Going to be tough to top last year's Barbenheimer. Rumours of the death of movies have been exaggerated. It's going to be a season-to-season, year-to-year stock, rather than a cyclical.

WATCH

Covid hammered them, while a British company tried to buy them but aborted that deal (now in a lawsuit). It's not cheap seeing a movie, but he goes now and then. Movies are coming back, though. You can't duplicate the experience at home. Still a lot of uncertainty with this stock, though.

RISKY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

Revenue growth is coming back a bit, with lower comparables from last year helping the year-over-year figures. Its debt levels are high, with net debt of $1.9B, and a net debt/EBITDA of 6.8X. Interest costs are $137M (last 12 months) and these will likely rise a bit with higher rates. 12-month cash flow was $116M and therein lies the problem. The debt is mostly due in the next five years. With attendance back, and a decent film slate, bankruptcy is becoming less of a concern, but it is still hard to paint a really positive picture here because of the leverage.

It is somewhat cheap (0.4X forward sales), but also has a fairly high forward P/E of 20.2X. It could become a takeover target, however, we would not place a high level of probability on that at these current levels.
Unlock Premium - Try 5i Free

PARTIAL BUY

Allan Tong’s Discover Picks

Cineplex remains a recovery story, and its beta of 2.88 signals more risk than usual. It rose 10% in Q1, but the chart was choppy. So, consider Cineplex a partial buy. After all, Covid didn’t kill cinema-going, as some expected, but deferred it. We still love the big screen. Read Dark horses: Nuvei, Cineplex, Boralex for our full analysis.

DON'T BUY

Too many good shows on competing streaming services. Kids don't go to a movie every Friday the way he used to. Doesn't know what the catalyst is. Dividend gone. Balance sheet probably not in good shape, pandemic did lots of damage. All depends on quality of movies. Media companies all losing money. No growth tailwinds over the next 5 years.

DON'T BUY

Business increasing with post pandemic business. Hard to make as much profit with rise of streaming. Company doing well with snacks/drinks purchases in theater. Unsure of the future of the theater business.

DON'T BUY

Negative shareholders' equity of 256M. Trying to hold its level. Movie releases generate positive news, but he can't assess long-term fundamentals. Pass. Look for value elsewhere.

DON'T BUY

Tricky sector to invest in at the moment(headwinds with the emergence of streaming technology). Large global cinema operators going bankrupt. Consumers looking to reduce spending with higher interest rates and inflation. Hard time to be in this business.

PARTIAL BUY

Allan Tong’s Discover Picks With a monopoly in Canadian moviegoing, Cineplex stock has nowhere to go but up. But how far? It's no secret that Covid ravaged its operations and killed the Cineworld takeover. That case is now crawling through the courts as the UK chain appeals the C$1.23 billion in damages found against it. I doubt that Cineworld will win, but I also doubt that Cineworld will pay Cineplex the full amount. I also suffer no illusions that Cineplex will return anywhere near its past highs of $50+ back in 2017. However, it should at least return to $16 last seen in June 2021 and even surpass it. Read Looking ahead with 2 Canadian Stocks for our full analysis.

RISKY

Takeover deal fell through so they might get some sort of breakup fee. Stock's recovered somewhat. Attendance is still very weak. Very high risk play. Should benefit from the economy reopening. For gamblers.

DON'T BUY

People own this for the dividend, and pre-Covid this company was innovative with preferred seating and cafes, and programming opera and sports. But this is a difficult environment now; he doesn't see people returning to cinemas given social distancing. Also, the studios are releasing films on streaming. True, a lot of blockbusters will be released, but those films will also be released at home, too.

DON'T BUY

Has been a confounding company. With covid and all that has happened in the past year, hard to see a near future where it is profitable again. People will go back to the movies, but it will be a slow recovery. Not a huge fan of CGX.

SELL

Difficulty is that we're still in the pandemic. A lot of content has moved to streaming, so it will be hard to get people back to the theatre, plus logistical problems of health safety. The movie Black Widow will be an interesting test case.

PARTIAL BUY

Allan Tong’s Discover Picks As a stock, where does Cineplex lie? Common metrics won’t work with CGX stock. For starters, YOY comps don’t exist. Meanwhile, the Cineworld lawsuit is a cloud. In the past week, Cineplex has probably enjoyed some momentum from the AMC euphoria and has climbed about $1 to $16.15 (Monday’s close). Right before the pandemic, Cineplex was trading above $33, though well off its 2017 peak of around $53. The street has three holds and one buy at a price target of $13.13, or almost 18% downside. I disagree. I see a little more upside here. CGX stock is an unscientific gut feeling call as a cautious, partial buy. Read 3 Hot TSX Stocks for our full analysis.

DON'T BUY

It's a very difficult story. People will take time returning to the cinemas. Cineplex did a good job offering ancillary services. Also, film studios like Disney are rethinking how they will exhibit movies (i.e. streaming). Will the Marvel blockbusters return to big screens?

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Brian MaddenCineplex IncCGX.TODON'T BUYAug 30, 2017

You might be interested:

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Cineplex Inc(CGX.TO)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Stockchase Insights

Brian Acker, CA

The Weekly Buzzing Stocks by Billy Kawasaki

David Burrows

Jim Cramer - Mad Money